Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline

Ray E. Hershberger, Joann Lindenfeld, Luisa Mestroni, Christine E. Seidman, Matthew R.G. Taylor, Jeffrey Towbin

Research output: Contribution to journalArticle

336 Citations (Scopus)

Abstract

Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and left ventricular noncompaction (LVNC). HCM, DCM, and RCM have been recognized as distinct clinical entities for decades, whereas ARVD/C and LVNC are relative newcomers to the field. Hence the clinical and genetic knowledge for each cardiomyopathy varies, as do the recommendations and strength of evidence.

Original languageEnglish (US)
Pages (from-to)83-97
Number of pages15
JournalJournal of Cardiac Failure
Volume15
Issue number2
DOIs
StatePublished - Mar 1 2009

Fingerprint

Cardiomyopathies
Practice Guidelines
Arrhythmogenic Right Ventricular Dysplasia

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline. / Hershberger, Ray E.; Lindenfeld, Joann; Mestroni, Luisa; Seidman, Christine E.; Taylor, Matthew R.G.; Towbin, Jeffrey.

In: Journal of Cardiac Failure, Vol. 15, No. 2, 01.03.2009, p. 83-97.

Research output: Contribution to journalArticle

Hershberger, Ray E. ; Lindenfeld, Joann ; Mestroni, Luisa ; Seidman, Christine E. ; Taylor, Matthew R.G. ; Towbin, Jeffrey. / Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline. In: Journal of Cardiac Failure. 2009 ; Vol. 15, No. 2. pp. 83-97.
@article{53c4c657ba8d4838bbe1bd33ad52baf2,
title = "Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline",
abstract = "Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and left ventricular noncompaction (LVNC). HCM, DCM, and RCM have been recognized as distinct clinical entities for decades, whereas ARVD/C and LVNC are relative newcomers to the field. Hence the clinical and genetic knowledge for each cardiomyopathy varies, as do the recommendations and strength of evidence.",
author = "Hershberger, {Ray E.} and Joann Lindenfeld and Luisa Mestroni and Seidman, {Christine E.} and Taylor, {Matthew R.G.} and Jeffrey Towbin",
year = "2009",
month = "3",
day = "1",
doi = "10.1016/j.cardfail.2009.01.006",
language = "English (US)",
volume = "15",
pages = "83--97",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "2",

}

TY - JOUR

T1 - Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline

AU - Hershberger, Ray E.

AU - Lindenfeld, Joann

AU - Mestroni, Luisa

AU - Seidman, Christine E.

AU - Taylor, Matthew R.G.

AU - Towbin, Jeffrey

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and left ventricular noncompaction (LVNC). HCM, DCM, and RCM have been recognized as distinct clinical entities for decades, whereas ARVD/C and LVNC are relative newcomers to the field. Hence the clinical and genetic knowledge for each cardiomyopathy varies, as do the recommendations and strength of evidence.

AB - Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and left ventricular noncompaction (LVNC). HCM, DCM, and RCM have been recognized as distinct clinical entities for decades, whereas ARVD/C and LVNC are relative newcomers to the field. Hence the clinical and genetic knowledge for each cardiomyopathy varies, as do the recommendations and strength of evidence.

UR - http://www.scopus.com/inward/record.url?scp=60949103027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60949103027&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2009.01.006

DO - 10.1016/j.cardfail.2009.01.006

M3 - Article

VL - 15

SP - 83

EP - 97

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 2

ER -